0.155 USD
+0.02 (+12.4%)
0.1452 USD
-0.01 (-6.32%)
ChartMill assigns a Buy % Consensus number of 80% to VIRI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.43. This target is 821.29% above the current price.
VIRI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VIRI.
In the previous month the buy percentage consensus was at a similar level.
VIRI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-09 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-06-20 | Maxim Group | Initiate | Buy |
| 2022-09-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-12-15 | HC Wainwright & Co. | Initiate | Buy |
VIRIOS THERAPEUTICS INC / VIRI FAQ
Can you provide the average price target for VIRIOS THERAPEUTICS INC stock?
8 analysts have analysed VIRI and the average price target is 1.43 USD. This implies a price increase of 821.29% is expected in the next year compared to the current price of 0.155.
Can you provide the consensus rating for VIRIOS THERAPEUTICS INC stock?
The consensus rating for VIRIOS THERAPEUTICS INC (VIRI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.